Related content

Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers

By Chotiyaputta Watcharasak  

Hepatology International, Vol. 4, Iss. 4, 2010-12 ,pp. : 707-715

Springer Publishing Company

Access to resources Recommend Favorite

Current use of hepatitis B immune globulin for prevention of de novo hepatitis B in recipients receiving anti-HBc-positive livers

By Pan Jen-Jung  

Hepatology International, Vol. 5, Iss. 2, 2011-06 ,pp. : 635-643

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus

By Drosten C.   Nippraschk T.   Manegold C.   Meisel H.   Brixner V.   Roth W.K.   Apedjinou A.   Gunther S.  

Journal of Clinical Virology, Vol. 29, Iss. 1, 2004-01 ,pp. : 59-68

Elsevier

Access to resources Recommend Favorite

Prophylaxis with anti-HBs immune globulins and nucleoside analogues after liver transplantation for HBV infection

By Villamil F.G.  

Journal of Hepatology, Vol. 39, Iss. 4, 2003-10 ,pp. : 466-474

Elsevier

Access to resources Recommend Favorite

Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus

By Roskams T.  

Journal of Hepatology, Vol. 39, Iss. 3, 2003-09 ,pp. : 431-434

Elsevier

Access to resources Recommend Favorite